ERBB2 and neoplasm: Complex molecular bidirectional crosstalk between the ER and HER2 pathways may perpetuate tumor growth and survival [19,23,24,25], with signaling through ER being a preferred escape pathway to HER2 inhibition [23,26,27,28] and HER2 being a preferred escape from ER inhibition [29,30,31].